Dihexa
PNB-0408 · N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
A small oligopeptide derivative and angiotensin IV analog developed in academic research as a procognitive compound. In preclinical models it is reported to potentiate hepatocyte growth factor (HGF) and its c-Met receptor, associated with synaptogenesis. Research material not approved for human use.
Half-life
Not established in humans; engineered for metabolic stability relative to native angiotensin IV (no published human PK). Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Small-molecule solid; store cool and dry, protected from light and moisture, in a sealed container.
References
- McCoy et al. (Dihexa / angiotensin IV analog, HGF/c-Met)
- Wright & Harding, angiotensin IV cognition research
Related in Cognitive / Longevity
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.